See also this year's filing and all EDGAR filings for this company.
PDF Report 0001818794_2022_Dyne_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001818794')"} |
Graph
Absolute values for 0001818794, Dyne Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 382,392,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,678,000 |
| 3 | remainder_Assets | 38,593,000 |
| 4 | LiabilitiesCurrent | 28,723,000 |
| 5 | LiabilitiesNoncurrent | 28,743,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 28,717,000 |
| 9 | ResearchAndDevelopmentExpense | 121,308,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 734,000 |
| 13 | remainder_ComprehensiveNetIncome | -242,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 425,663,000 |
| 1 | Liabilities | 57,466,000 |
| 2 | Expenses | 150,025,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 368,197,000 |
| 5 | NetIncome | -149,291,000 |
| 6 | ComprehensiveNetIncome | -149,412,000 |
| 7 | BaseVar | 317,065,000 |
| 8 | EconomicCapitalRatio | 2.00 |
Edgar->Model Mapping
Feature Distribution
Change over Time
